New Delhi: Drug major Ranbaxy said, on Wednesday, it will spend nearly ¥200 million (over Rs 10 crore) along with parent company Daiichi Sankyo over the next five years to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania.
The services will be provided in the fields of basic healthcare, immunization, maternal and child health services and health education over a five-year period, involving a total monetary contribution of nearly ¥200 million, the company said in a statement.
The initiative will be implemented in India through the Ranbaxy Community Health Care Society and in Cameroon and Tanzania through an international Non-Governmental Organization (NGO), Plan Japan, it said.
“India is among the countries with the highest number of infant and maternal mortalities in the world and Cameroon and Tanzania have some of the highest infant mortality rates and maternal mortality ratios among developing countries in Africa,” it added.
This initiative will contribute directly in improving the lives and health of citizens who lack such access in the three countries, it added.
This is being done as part of the company’s global social contribution activities and is in alignment with the United Nation’s global ‘Millennium Development Goals´ for reducing child mortality, improving maternal health and combating HIV/AIDS, malaria and other diseases, Ranbaxy said.